The number needed to vaccinate (NNV) and population extensions of the NNV: Comparison of influenza and pneumococcal vaccine programmes for people aged 65 years and over

Vaccine

Volumn 22, Issue 17-18, 2004, Pages 2192-2198

  Kelly, Heath ^a   Attia, John ^b   Andrews, Ross ^c   Heller, Richard F ^d  

^a VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Influenza vaccine; Number needed to vaccinate; Pneumococcal vaccine

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

AGE DISTRIBUTION; AGED; CALCULATION; CLINICAL TRIAL; COMPARATIVE STUDY; DEATH; DOSE RESPONSE; DRUG COST; HEALTH CARE COST; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION PREVENTION; INFLUENZA; META ANALYSIS; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; STREPTOCOCCUS INFECTION; VACCINATION;

EID: 2442517377     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.11.052     Document Type: Article

References (27)

1. National Health and Medical Research Council. How to compare the costs and benefits: evaluation of the economic evidence. Handbook series on preparing clinical practice guidelines. Canberra: Commonwealth of Australia; 2001.
2. Gold M, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
3. Laupacis A., Sackett D.L., Roberts D.S. An assessment of clinically useful measures of the consequences of treatment. N. Engl. J. Med. 318:1988;1728-1733
4. Heller R.F., Dobson A.J. Disease impact number and population impact number: population perspective to measures of risk and benefit. BMJ. 321:2000;950-953
5. Attia J., Page J., Heller R.F., Dobson A.J. Impact numbers in health policy decisions. J. Epidemiol. Community Health. 56:2002;600-605
6. Nicholson K.G., Kent J., Hammersley V. Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden in the community. BMJ. 315:1997;1060-1064
7. Govaert T.M., Thijs C.T., Masurel N., Sprenger M.J., Dinant G.J., Knottnerus J.A. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA. 272:1994;1661-1665
8. Sullivan K.M. Health impacts of influenza in the United States. Pharmaco. Econ. 9(Suppl 3):1996;26-33
9. McIntyre P.B., Gilmour R.E., Gilbert G.L., Kakakios A.M., Mellis C.M. Epidemiology of invasive pneumococcal disease in urban New South Wales 1997-1999. Med. J. Aust. 173(Suppl.):2000;S22-6
10. Fedson D.S., Scott J.A., Scott G. The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known. Vaccine. 17(Suppl. 1):1999;S11-8
11. Roche P., Spencer J., Hampson A. Annual report of the national influenza surveillance scheme, 2001. Commun. Dis. Intell. 26:2002;204-213
12. Vu T., Farish S., Jenkins M., Kelly H. A meta-analysis of influenza vaccine in persons aged 65 years and over living in the community. Vaccine. 20:2002;1831-1836
13. Shapiro E.D., Berg A.T., Austrian R., Schroeder D., Parcells V., Margolis A., et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N. Engl. J. Med. 325:1991;1453-1460
14. Butler J.C., Breiman R.F., Campbell J.F., Lipman H.B., Broome C.V., Facklam R.R., et al. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA. 270:1993;1826-1831
15. National Health and Medical Research Council. The Australian immunisation handbook. 7th ed. Canberra: Australian Government Publishing Service; 2000.
16. National Health and Medical Research Council. The Australian immunisation handbook. 8th ed. (draft). Available at http://www.health.gov.au/pubhlth/ immunise/schedule.htm.
17. Australian Institute of Health and Welfare. 2002 Influenza Vaccine Survey. Summary results. Catalogue no. PHE-46. Published online at (http://www.aihw.gov.au/publications). Available from April 4, 2003.
18. Postma M.J., Bos J.M., van Gennep M., Jager J.C., Baltussen R., Sprenger J.W. Economic evaluation of influenza vaccination. Assessment for The Netherlands. Pharmaco Econ. Suppl. 16(Suppl. 1):1996;33-40
19. Nichol K.L., Goodman M. Cost effectiveness of influenza vaccination for healthy persons between ages 65 and 74 years. Vaccine. 20(Suppl. 2):2002;S21-4
20. Ament A., Baltussen R., Duru G., Rigand-Bully C., de Graeve D., Ortqvist A., et al. Cost-effectiveness of pneumococcal vaccination of older people: a study in 5 western European countries. Clin. Infect. Dis. 31:2000;444-450
21. Sisk J.E., Moskowitz A.J., Whang W., Lin J.D., Fedson D.S., McBean A.M., et al. Cost-effectiveness of vaccination against pneumococcal bacteraemia among elderly people. JAMA. 278:1997;1333-1339
22. Sprenger M.J., Mulder P.G., Beyer W.E., Van Strik R., Masurel N. Impact of influenza on mortality in relation to age and underlying disease. 1967-1989. Int. J. Epidemiol. 22:1993;34-40
23. Jennings R., Smith T.L., Mellersh A.R., Clark A., Spencer R.C., Potter C.W. Antibody response and persisitence in volunteers following immunization with varying dosages of a trivalent surface antigen influenza virus vaccine. J. Hyg. (Lond.). 94:1985;87-94
24. Hashimoto S., Murakami Y., Taniguchi K., Shindo N., Osaka K., Fuchigami H., et al. Annual incidence rate of infectious diseases estimated from sentinel surveillance data in Japan. J. Epidemiol. 13:2003;136-141
25. Fleming D.M., Zambon M., Bartelds A.I. Population estimates of persons presenting to general practitioners with influenza-like illness, 1987-96: a study of the demography of influenza-like illness in sentinel practice networks in England and Wales, and in The Netherlands. Epidemiol. Infect. 124:2000;245-253
26. Nichol K.L., Nordin J., Mullooly J., Lask R., Fillbrandt K., Iwane M. Influenza vaccination and reduction in hospitalisations for cardiac disease and stroke in the elderly. N. Engl. J. Med. 384:2003;1322-1332
27. Australian Government Actuary. Australian Life Tables 1995-1999. Canberra: Australian Prudential Regulation Authority; 1999.